Smart Cervical Cancer Screening Devices Could Make Early Detection a Global Reality 28/04/2022 Maayan Hoffman Qalansawe, Israel – The women, heads covered in hijabs, sat outside a small purple aluminium mobile health station parked in a residential neighbourhood here, shooing away any men who happened to pass by. Plastic chairs formed a small and intimate circle for the women waiting to be screened for cervical cancer – some for the […] Continue reading -> Record-breaking Heatwaves in India and Pakistan Affect Over Billion People 27/04/2022 Kerry Cullinan More than a billion people in India and Pakistan are expected to face temperatures of over 40ºC in the next few days, peaking as high as 50Cº in Pakistan as record-breaking heatwaves that began in early March continue to affect South East Asia. The heat is also jeopardising India’s wheat exports, which are even more […] Continue reading -> Tigray’s Health System ‘Totally Collapsed’, say Health Workers 27/04/2022 Fred Harter, The New Humanitarian ADDIS ABABA – After nearly 18 months of conflict between the Ethiopian federal government and Tigray rebels, the health system of the beleaguered region has “totally collapsed”, according to health officials and doctors there. Health workers in Tigray told The New Humanitarian by phone that shortages are so acute they are using expired drugs to […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Record-breaking Heatwaves in India and Pakistan Affect Over Billion People 27/04/2022 Kerry Cullinan More than a billion people in India and Pakistan are expected to face temperatures of over 40ºC in the next few days, peaking as high as 50Cº in Pakistan as record-breaking heatwaves that began in early March continue to affect South East Asia. The heat is also jeopardising India’s wheat exports, which are even more […] Continue reading -> Tigray’s Health System ‘Totally Collapsed’, say Health Workers 27/04/2022 Fred Harter, The New Humanitarian ADDIS ABABA – After nearly 18 months of conflict between the Ethiopian federal government and Tigray rebels, the health system of the beleaguered region has “totally collapsed”, according to health officials and doctors there. Health workers in Tigray told The New Humanitarian by phone that shortages are so acute they are using expired drugs to […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tigray’s Health System ‘Totally Collapsed’, say Health Workers 27/04/2022 Fred Harter, The New Humanitarian ADDIS ABABA – After nearly 18 months of conflict between the Ethiopian federal government and Tigray rebels, the health system of the beleaguered region has “totally collapsed”, according to health officials and doctors there. Health workers in Tigray told The New Humanitarian by phone that shortages are so acute they are using expired drugs to […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Drug-Resistant Infections Kill More Newborns as Doctors Run Out of Treatment Options 26/04/2022 Kerry Cullinan More newborn babies with sepsis are dying because their infections are not responding to the usual antibiotics, according to the biggest global study on the subject yet. The study’s sponsor, the Global Antibiotic Research and Development Partnership (GARDP), is now designing an interventional trial to identify better treatment regimens. to combat rising resistance. GARDP’s study, […] Continue reading -> Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Malaria, Polio, and COVID-19: Lessons for Existing and Future Pandemics 26/04/2022 Sarthak Das, Aidan O’Leary & Shekhar Mehta On the occasion of World Immunization Week, influential global health figures share lessons learned in the global fight against two age-old diseases, malaria and polio – and more recently, COVID-19 – and how we should tackle existing and future pandemics. While COVID-19 surprised and shocked the world, it should not have. For decades, infectious […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Posts navigation Older Posts Newer Posts